35 Pa. Stat. § 631.5
Current through Pa Acts 2024-53, 2024-56 through 2024-92
The use of a drug or biologic which is prepackaged with an administration system or used in a prefilled syringe and is approved for commercial distribution or investigational use by the United States Food and Drug Administration is exempt from standards adopted under this act for a period of three years from the effective date of this act.
35 P.S. § 631.5